Hemodilution of prostate-specific antigen levels among obese men

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 8, 2009, Pages 2343-

  Rundle, Andrew ^a   Richards, Catherine ^a   Neugut, Alfred I ^a,b  

^a Mailman School of Public Health   (United States)

^b Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD VOLUME; BODY FAT; BODY HEIGHT; BODY MASS; BODY SURFACE; CLINICAL DECISION MAKING; FOLLOW UP; HEMODILUTION; HUMAN; LETTER; OBESITY; PRIORITY JOURNAL; VASCULARIZATION;

HUMANS; MALE; OBESITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE VALUES;

EID: 68949114050     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0441     Document Type: Letter

References (4)

1. Grubb RL III, Black A, Izmirlian G, et al. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2009;18:748-51.
2. Banez LL, Hamilton RJ, Partin AW, et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007;298:2275-80.
3. Rundle A, Neugut AI. Obesity and screening PSA levels among men undergoing an annual physical exam. Prostate 2008;68:373-80.
4. Rundle A, Richards C, Neugut AI. Body composition, abdominal fat distribution, and prostate-specific antigen test results. Cancer Epidemiol Biomarkers Prev 2009;18:331-6.